Improving Cell Therapies to Repair Articular Cartilage Damage
Researchers will evaluate the ability of a unique population of cells called interzone cells to produce new cartilage in horses with joint damage.
Researchers will evaluate the ability of a unique population of cells called interzone cells to produce new cartilage in horses with joint damage.
Researchers will investigate genetic risk factors for equine recurrent uveitis, a common eye condition and leading cause of blindness in horses.
Researchers will investigate how to improve diagnosis and treatment of equine insect bite hypersensitivity, one of the most common allergic skin diseases in horses.
Researchers will search for genetic mutations associated with mitral valve disease, a common heart condition in small breed dogs, to improve disease management and prevention.
Researchers will evaluate the efficacy of a vaccine for visceral leishmaniasis, a parasitic disease, in United States foxhounds.
Researchers are studying a group of 80 dogs with osteosarcoma to generate comparison data for ongoing and future studies of new chemotherapeutic agents.
Researchers will investigate the role of a small protein released in response to inflammation as a potential new therapy target to control itch and inflammation in dogs with chronic, relapsing allergic skin disease.